Skip to main content

CORRECTION article

Front. Neurol., 15 June 2023
Sec. Neurogenetics
Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1227084

Corrigendum: Clinical and genetic analysis of Costa Rican patients with Parkinson's disease

\r\nGabriel Torrealba-Acosta, &#x;Gabriel Torrealba-Acosta1,2*†Eric Yu,&#x;Eric Yu3,4†Tanya Lobo-Prada,Tanya Lobo-Prada2,5Javier Ruíz-Martínez,,Javier Ruíz-Martínez6,7,8Ana Gorostidi-Pagola,,Ana Gorostidi-Pagola7,8,9Ziv Gan-Or,,Ziv Gan-Or3,4,10Kenneth Carazo-CspedesKenneth Carazo-Céspedes11Jean-Franois TrempeJean-François Trempe12Ignacio F. MataIgnacio F. Mata13Jaime Fornaguera-Trías,Jaime Fornaguera-Trías2,5
  • 1Department of Neurology and Neurosurgery, Baylor College of Medicine, Houston, TX, United States
  • 2Neurosciences Research Center, Universidad de Costa Rica, San José, Costa Rica
  • 3Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada
  • 4Department of Human Genetics, McGill University, Montreal, QC, Canada
  • 5Department of Biochemistry, Medicine School, Universidad de Costa Rica, San José, Costa Rica
  • 6Group of Neurodegenerative Diseases, Biodonostia Health Research Institute, San Sebastian, Spain
  • 7CIBERNED, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain
  • 8Movement Disorders Unit, Neurology Department, Donostialdea Integrated Health Organisation, Osakidetza Basque Health Service, San Sebastian, Spain
  • 9Genomic Platform, Biodonostia Health Research Institute, San Sebastian, Spain
  • 10Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada
  • 11Department of Neurology, Hospital San Juan de Dios, Caja Costarricense de Seguro Social, San José, Costa Rica
  • 12Department of Pharmacology and Therapeutics and Centre de Recherche en Biologie Structurale, McGill University, Montreal, QC, Canada
  • 13Cleveland Clinic Foundation, Genomic Medicine, Lerner Research Institute, Cleveland, OH, United States

A corrigendum on
Clinical and genetic analysis of Costa Rican patients with Parkinson's disease

by Torrealba-Acosta, G., Yu, E., Lobo-Prada, T., Ruíz-Martínez. J., Gorostidi-Pagola. A., Gan-Or, Z., Carazo-Céspedes, K., Trempe, J.-F., Mata, I. F., and Fornaguera-Trías, J. (2021). Front. Neurol. 12:656342. doi: 10.3389/fneur.2021.656342

In the published article, there was an error. The stated number of protocols needed to be corrected. These errors were identified after an audit conducted by the CONIS (Consejo Nacional de Investigacion en Salud) of Costa Rica.

A correction has been made to the Ethics Statement. This statement previously stated:

The studies involving human participants were reviewed and approved by Ethics Committee of Hospital San Juan de Dios, Caja Costarricense de Seguro Social (CLOBI-HSJD #014- 2015) and the University of Costa Rica (837-B5-304). The patients/participants provided their written informed consent to participate in this study.

The corrected statement appears below:

The studies involving human participants were reviewed and approved by the Ethics Committee of the University of Costa Rica (VI-3668-2014 and final report 837-B5-302). The patients/participants provided their written informed consent to participate in this study.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Parkinson's disease, genotype, phenotype, Costa Rica, Latin America

Citation: Torrealba-Acosta G, Yu E, Lobo-Prada T, Ruíz-Martínez J, Gorostidi-Pagola A, Gan-Or Z, Carazo-Céspedes K, Trempe J-F, Mata IF and Fornaguera-Trías J (2023) Corrigendum: Clinical and genetic analysis of Costa Rican patients with Parkinson's disease. Front. Neurol. 14:1227084. doi: 10.3389/fneur.2023.1227084

Received: 22 May 2023; Accepted: 01 June 2023;
Published: 15 June 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Torrealba-Acosta, Yu, Lobo-Prada, Ruíz-Martínez, Gorostidi-Pagola, Gan-Or, Carazo-Céspedes, Trempe, Mata and Fornaguera-Trías. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Gabriel Torrealba-Acosta, gabriel.torrealbaacosta@bcm.edu

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.